MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Retained Earnings (2015 - 2026)

MetaVia's (MTVA) quarterly Retained Earnings came in at -$148.8 million in Q4 2025, down 9.53% YoY from -$164.5 million in Q4 2024, and down 1.29% on a QoQ basis from -$146.9 million in Q3 2025.

MetaVia (MTVA) Retained Earnings (2015 - 2026) Analysis & Trends

MetaVia (MTVA) has 11 years of Retained Earnings data on file, last reported at -$148.8 million in Q4 2025.

  • Quarterly Retained Earnings fell 9.53% year-over-year to -$148.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$148.8 million (down 9.53% YoY) and the FY2025 annual result came in at -$148.8 million, down 9.53% from the prior year.
  • Retained Earnings fell to -$148.8 million in Q4 2025, from -$146.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $153.1 million in Q2 2025 to a low of -$148.8 million in Q4 2025.
  • A 5-year average of $13.4 million and a median of $5500.0 in 2021 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2022 — Retained Earnings slumped 2277600.0% — and 2023, when it surged 3962566.67%.
  • Tracing MTVA's Retained Earnings over 5 years: stood at $96.4 million in 2021, then rose by 21.88% to $117.5 million in 2022, then increased by 6.32% to $124.9 million in 2023, then sank by 208.73% to -$135.9 million in 2024, then decreased by 9.53% to -$148.8 million in 2025.
  • The last three Retained Earnings figures came in at -$148.8 million (Q4 2025), -$146.9 million (Q3 2025), and $153.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.10 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 13.05 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -6.33 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 20.91 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.57 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 4.38 Bn
10 MetaVia 8.72 Mn -3.92 Mn - 164.78 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 164.78 Mn
Dec 31, 2025 -148.80 Mn
Sep 30, 2025 -146.90 Mn
Jun 30, 2025 153.12 Mn
Mar 31, 2025 143.90 Mn
Dec 31, 2024 -135.86 Mn
Sep 30, 2024 143.63 Mn
Jun 30, 2024 143.97 Mn
Mar 31, 2024 -115.00 Mn
Dec 31, 2023 124.95 Mn
Sep 30, 2023 124.46 Mn
Jun 30, 2023 -99.10 Mn
Mar 31, 2023 118.88 Mn
Dec 31, 2022 117.52 Mn
Sep 30, 2022 -91.10 Mn
Jun 30, 2022 -88.00 Mn
Mar 31, 2022 3,000.00
Dec 31, 2021 96.42 Mn
Sep 30, 2021 4,000.00
Jun 30, 2021 -73.79 Mn